Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel Member Conflict: Cognitive and Neuropathological signatures of Alzheimer's Disease, Brain Injury and Aging.                    

*Date:*                         March 23, 2021.                    

*Time:*                         9:30 a.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Samuel C. Edwards, Ph.D., Chief, BDCN IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846 Bethesda, MD 20892, (301) 435-1246,                         *edwardss@csr.nih.gov*.                    

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; PAR Panel: Fogarty Global Brain Disorders.                    

*Date:*                         March 23-24, 2021.                    

*Time:*                         9:30 a.m. to 7:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Suzan Nadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217B, MSC 7846 Bethesda, MD 20892 301-435-1259                         *nadis@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review, Special Emphasis Panel; Member Conflict: Child Psychopathology, Developmental Disabilities, and Mechanisms of Anxiety and Depression.                    

*Date:*                         March 25, 2021.                    

*Time:*                         1:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Biao Tian, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3089B, MSC 7848 Bethesda, MD 20892, (301) 402-4411                         *tianbi@csr.nih.gov*.                    

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Small Business: Antiviral Therapeutics.                    

*Date:*                         March 29-30, 2021.                    

*Time:*                         9:00 a.m. to 1:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Bidyottam Mittra, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20894 301-435-4057                         *bidyottam.mittra@nih.gov*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Member conflict: Dermatology Development and Disease.                    

*Date:*                         March 29, 2021.                    

*Time:*                         12:30 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Richard Ingraham, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4116, MSC 7814 Bethesda, MD 20892, (301) 496-8551                         *ingrahamrh@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

 Dated: February 24, 2021.

Ronald J. Livingston, Jr.,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-04229 Filed 3-1-21; 8:45 am]

BILLING CODE 4140-01-P